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between departments was required to facilitate the investigation,
screening, and PEP process.
Results: 294 HCWs were identiﬁed as having physical contact
with the organ recipients. 272 HCWs were considered low risk not
requiring PEP. 12 were lost to follow-up due to resignation. 10
HCWs received PEP: 3 due to a high risk procedure, 2 with an unre-
ported splash exposure, and 5 due to an unsure exposure risk. 5
HCWs indicated inappropriate personal protective equipment use.
No HCW developed RVD.
Conclusion: The investigation identiﬁed areas for improve-
ment; poor compliance with infection control practices, under-
reporting of exposures, and organ donations from high risk
countries to include screening forRVD if causeof death is associated
with non-speciﬁc encephalitis.
http://dx.doi.org/10.1016/j.ijid.2016.02.480
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Background: Statistically signiﬁcant variation in antimicrobial
resistance (AMR) occurs between hospitals, within hospitals, and
over time. Whilst case mix and antimicrobial use contribute, the
impact of cross-transmission on these ﬂuctuations is not well
understood. We investigated the utility of applying a statistical
algorithm to identify outbreaks of carbapenem-resistant infections
across three critical care units in a multi-centre teaching hospital
network serving a population of 2 million in London, UK.
Methods & Materials: We applied a negative binomial regres-
sion model which accounts for seasonality and linear trends, as
describedbyNoufaily et al., to routinely collectedmicrobiologydata
(ﬁscal years 2009-2015 for two units, 2012-2015 for the third) for
carbapenem-resistant Pseudomonas spp. and Enterobacteriaceae
(CRE). The ﬁrst two years of data for each unit was used to train
the algorithm. Exceedances (i.e. weeks with possible outbreaks)
were validated by antibiogram comparison (as a proxy-indicator
of strain similarity), against hospital infection control reports, and
where available through genotypic typing.
Results: Across the three units, 154 CRE (from 3640 Enterobac-
teriaceae) were identiﬁed. The algorithm identiﬁed 17 exceedance
weeks, in 11 multi-week clusters. In four of these clusters (three K.
pneumoniae, one E. coli) organisms shared identical antibiograms;
typingwasavailable for oneK. pneumoniae cluster, indicating clonal
NDM cross-transmission, and this was the only outbreak (of the
11 clusters) identiﬁed in hospital infection control reports. Among
786 carbapenem-resistant Pseudomonas spp. (from 2378 isolated),
27 exceedance weeks were detected, in 15 multi-week clusters.
Organisms in eight clusters shared identical antibiograms. No typ-
ing was available and none of the clusters had been identiﬁed in
hospital infection control reports. No additional outbreaks of CRE
or carbapenem-resistantPseudomonas spp.were identiﬁed through
routine surveillance or in hospital infection control reports.
Conclusion: The rise of carbapenem resistant organisms neces-
sitates low-cost, easy-to-use surveillance mechanisms to aid early
identiﬁcation of outbreaks, particularly in critical care. Our data
suggests such outbreaks may be more common than previously
thought, and may be going undetected by current surveillance sys-
tems. Application of the Noufaily algorithm to routinely collected
microbiology data provides a valid mechanism to better target
limited hospital epidemiology, infection control, and diagnostics
resources.
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Background: Cross-sectional, population-based seropreva-
lence studies provide data on exposure to pathogens, susceptibility
and disease transmission dynamics, and are useful in public health
and vaccination planning. Cross-reactivity between ﬂavivirus IgG
antibody assays is an important consideration where multiple ﬂa-
viviruses co-circulate.
Methods & Materials: An age-stratiﬁed dengue and Japanese
encephalitis virus (JEV) IgG seroprevalence study was conducted
in 8 sites across India, enrolling 2,591 subjects aged 5 – 10 years.
Sera were tested using commercial ELISA kits; those dengue posi-
tive were subjected to plaque reduction neutralization test (PRNT)
for serotype-speciﬁc neutralizing antibodies (DEN-1, 2, 3 and 4).
A threshold of ≥ 10 (1/dil) was considered detectable; an algo-
rithm was applied to interpret proﬁles as “naïve”, “monotypic”
or “multitypic”. This secondary analysis explored a hypothesis
that JEV IgG status was associated with cross-reactive dengue
antibodies. JEV IgG results were analyzed by: a) dengue IgG sta-
tus; b) naïve/monotypic/multitypic PRNT proﬁle; c) the number
of serotypes with detectable neutralizing antibodies; and d) geo-
metric mean neutralizing antibody titer (GMT). Associations were
tested by Pearson’s chi squared test.
Results: Overall, 1,525/2,558 (59.6%) of available samples were
dengue IgG positive, and 345/2,544 (13.6%) were positive for JEV
IgG. Of JEV positive samples, 327 (94.8%) were also dengue IgG
positive. Similarly, 96.5% of the 405 “inconclusive” JEV samples
were dengue positive. Of the 1,794 JEV IgG negative samples, 801
(44.6%)were dengue IgG positive (p<0.0001). Examining PRNT pro-
ﬁles, 0.62%, 25.3% and 74.1% of JEV positive samples were naïve,
monotypic andmultitypic, compared to4.5%, 38.6%and56.9%of JEV
